FDA Adverse Event Malfunction Summary report: N

FLEXTEND II

MDR report key: 2041815 · Received April 6, 2011

Report

Report Number
2124215-2011-01156
Event Type
Malfunction
Date Received
April 6, 2011
Date of Event
December 19, 2010
Report Date
January 13, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO FURTHER PATIENT EFFECTS WERE REPORTED. AN ATTEMPT WAS MADE TO RETRIEVE ADDITIONAL INFORMATION FROM THE FIELD CONCERNING THE FINAL OUTCOME OF THIS EVENT, HOWEVER, NO FURTHER INFORMATION HAS BEEN RECEIVED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT ATRIAL (RA) LEAD HAD INCREASING HEART FAILURE SYMPTOMS. DURING A FOLLOW-UP, IT WAS NOTED THE RA LEAD HAD DISLODGED. THE PATIENT WAS HOSPITALIZED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| O